A multi-platform genomic analysis of paired well- and dedifferentiated liposarcoma identifies recurrent genomic alterations associated with progression and recurrence

Processed multi-platform genomic data for Crago et al., "A multi-platform genomic analysis of paired well- and dedifferentiated liposarcoma identifies recurrent genomic alterations associated with progression and recurrence (manuscript in preparation). The cohort spans 349 tumor specimens from 162 patients (1994–2013): 152 well-differentiated and 162 dedifferentiated liposarcomas with 35 normal-fibroblast controls. Included are Affymetrix HG-U133A tumor and cell-line expression matrices, array CGH segmentation lesions and event calls, VEP/FACETS-annotated whole-exome somatic MAF, RNA-seq gene counts, miRNA target predictions, sample annotations.